Trial intelligence / Profile preview

Intraperitoneal ketamine vs bupivacaine vs dexmedetomidine for postoperative pain after abdominal hysterectomy

IRCT20141209020258N130Phase 2Completed

Sponsor
Arak University of Medical Sciences
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in postoperative pain comparing Intraperitoneal dexmedetomidine, Intraperitoneal bupivacaine and Intraperitoneal ketamine (3 arms). Primary endpoints: Pain and Amount of drug used. Started Jan 2019; status: completed.

02

Drugs

dexmedetomidinebupivacaineketamine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20141209020258N130.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141209020258N130.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call